Enhancing glucose uptake has been attempted by insulin infusion called glucose–insulin–potassium (GIK) therapy, which involved exposure to high concentrations of insulin during acute ischemia (Sodi-Pallares et al., 1962). The gene discussed is INS; the disease is ischemia.